Investors’ Patience Is Being Tested Right Now By Alkermes plc (NASDAQ: ALKS)

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

Stocks Info

Alkermes plc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Alkermes plc is $5.15B. A total of 0.73 million shares were traded on the day, compared to an average of 1.79M shares.

In the most recent transaction, Parisi Samuel Joseph sold 1,938 shares of ALKS for 34.00 per share on Feb 28 ’25. After the transaction, the VP, Finance (Interim PAO) now owns 7,717 company shares. In a previous transaction on Feb 25 ’25, Parisi Samuel Joseph sold 3,743 shares at 35.26 per share. ALKS shares that VP, Finance (Interim PAO) owns now total 7,717.

Among the insiders who sold shares, Parisi Samuel Joseph disposed of 1,327 shares on Feb 20 ’25 at a per-share price of $35.69. This resulted in the VP, Finance (Interim PAO) holding 7,717 shares of ALKS after the transaction. In another insider transaction, Hopkinson Craig C. sold 204,921 shares at $32.78 per share on Feb 12 ’25. Company shares held by the EVP R&D, Chief Medical Officer now total 57,875.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ALKS has a high of $36.45 and a low of $22.90.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ALKS’s latest balance sheet shows that the firm has $536.31M in Cash & Short Term Investments as of fiscal 2021. There were $416.21M in debt and $471.29M in liabilities at the time. Its Book Value Per Share was $9.17, while its Total Shareholder’s Equity was $1.11B.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALKS is Buy with a score of 4.20.

Most Popular

Related Posts